Repligen Beneish M Score

RGEN
 Stock
  

USD 250.46  4.19  1.70%   

This module uses fundamental data of Repligen to approximate the value of its Beneish M Score. Repligen M Score tells investors if the company management is likely to be manipulating earnings. The score is calculated using eight financial indicators that are adjusted by a specific multiplier. Please note, the M Score is a probabilistic model and cannot detect companies that manipulate their earnings with 100% accuracy. Additionally, take a look at Repligen Piotroski F Score and Repligen Altman Z Score analysis.
  
Repligen Issuance Repayment of Debt Securities is quite stable at the moment as compared to the past year. The company's current value of Issuance Repayment of Debt Securities is estimated at 107.85 Million. Long Term Debt to Equity is expected to rise to 0.32 this year, although the value of Total Debt will most likely fall to about 85.2 M. Repligen Cash and Equivalents Turnover is quite stable at the moment as compared to the past year. The company's current value of Cash and Equivalents Turnover is estimated at 1.40. Return on Investment is expected to rise to 9.06 this year, although the value of PPandE Turnover will most likely fall to 6.38.
At this time, it appears that Repligen Cp is an unlikely manipulator. The earnings manipulation may begin if Repligen's top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by Repligen executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of Repligen's earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
-2.24
Beneish M Score - Unlikely Manipulator
Elasticity of Receivables1.0Focus
Asset Quality1.0Focus
Expense Coverage1.0Focus
Gross Margin Strengs1.13Focus
Accruals Factor1.0Focus
Depreciation Resistance1.0Focus
Net Sales Growth1.08Focus
Financial Leverage Condition0.99Focus

Repligen Beneish M-Score Indicator Trends

The cure to earnings manipulation is the transparency of financial reporting. It will typically remove the temptation of the top executives to inflate earnings (i.e., to promote the idea of 'winning at any cost'). Because a healthy internal audit department can enhance transparency, the board should promote the auditors' access to all the record-keeping systems across the enterprise. For example, if Repligen's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back.
Current ValueLast YearChange From Last Year 10 Year Trend
Revenues723.5 M670.5 M
Significantly Up
Increasing
Slightly volatile
Selling General and Administrative Expense30 M27.8 M
Significantly Up
Increasing
Slightly volatile
Net Cash Flow from Operations128.4 M119 M
Significantly Up
Increasing
Slightly volatile
Depreciation Amortization and Accretion5.2 M4.8 M
Significantly Up
Increasing
Slightly volatile
Total Assets2.5 B2.4 B
Significantly Up
Increasing
Slightly volatile
Investments20.6 M17.6 M
Fairly Up
Decreasing
Stable
Investments Current17.8 M17.6 M
Fairly Up
Increasing
Slightly volatile
Investments Non Current1.9 M1.9 M
Fairly Up
Decreasing
Slightly volatile
Property Plant and Equipment Net14.5 M13.5 M
Significantly Up
Increasing
Slightly volatile
Trade and Non Trade Receivables15.6 M14.4 M
Significantly Up
Increasing
Slightly volatile
Total Liabilities656.3 M608.3 M
Significantly Up
Increasing
Slightly volatile
Current AssetsB931.7 M
Significantly Up
Increasing
Slightly volatile
Assets Non Current101.7 M94.3 M
Significantly Up
Increasing
Slightly volatile
Current Liabilities404.9 M375.3 M
Significantly Up
Increasing
Slightly volatile
Liabilities Non Current96.2 M89.2 M
Significantly Up
Increasing
Slightly volatile
Total Debt85.2 M85.7 M
Slightly Down
Decreasing
Slightly volatile
Debt Non Current85.2 M85.7 M
Slightly Down
Decreasing
Slightly volatile
Operating Income180.5 M167.2 M
Significantly Up
Increasing
Slightly volatile
Gross Margin65.7858.3496
Moderately Up
Decreasing
Slightly volatile

Repligen Cp Beneish M-Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to detect the potential manipulation of earnings. Understanding the correlation between Repligen's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Repligen in a much-optimized way. Analyzing correlations between earnings drivers directly associated with dollar figures is the most effective way to find Repligen's degree of accounting gimmicks and manipulations.

About Repligen Beneish M Score

M-Score is one of many grading techniques for value stocks. It was developed by Professor M. Daniel Beneish of the Kelley School of Business at Indiana University and published in 1999 under the paper titled The Detection of Earnings Manipulation. The Beneish score is a multi-factor model that utilizes financial identifiers to compile eight variables used to classify whether a company has manipulated its reported earnings. The variables are built from the officially filed financial statements to create a final score call 'M Score.' The score helps to identify companies that are likely to manipulate their profits if they show deteriorating gross margins, operating expenses, and leverage against growing revenue.

Depreciation Amortization and Accretion

5.18 Million

Repligen Depreciation Amortization and Accretion is quite stable at the moment as compared to the past year. The company's current value of Depreciation Amortization and Accretion is estimated at 5.18 Million

Repligen Earnings Manipulation Drivers

Although earnings manipulation is typically not the result of intentional misconduct by the c-level executives, it is still a widespread practice by the senior management of public companies such as Repligen. It is usually done by a series of misrepresentations of various accounting rules and operating activities across multiple financial cycles. The best way to spot the manipulation is to examine the historical financial statement to find inconsistencies in earning reports to find trends in assets or liabilities that are not sustainable in the future.
201720182019202020212022 (projected)
Revenues141.24 M194.03 M270.25 M366.26 M670.53 M723.47 M
Total Assets743.52 M774.62 M1.4 B1.9 B2.36 B2.54 B
Current Assets242.78 M275.74 M641.83 M902.38 M931.68 M1.01 B
Total Liabilities151.97 M159.05 M340.35 M373.74 M608.29 M656.31 M
Current Liabilities25.21 M129.84 M48.31 M318.96 M375.26 M404.89 M
Operating Income14.01 M25.99 M36.08 M69.82 M167.25 M180.45 M
Gross Margin52.5355.455.9357.2358.3565.78

About Repligen Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Repligen Cp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Repligen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Repligen Cp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts. Repligen operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 1852 people.

Repligen Investors Sentiment

The influence of Repligen's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Repligen. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Repligen's public news can be used to forecast risks associated with investment in Repligen. The trend in average sentiment can be used to explain how an investor holding Repligen can time the market purely based on public headlines and social activities around Repligen Cp. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Repligen's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Repligen's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Repligen's news discussions. The higher the estimate score, the more favorable is the investor's outlook on Repligen.

Repligen Implied Volatility

    
  75.25  
Repligen's implied volatility exposes the market's sentiment of Repligen Cp stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Repligen's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Repligen stock will not fluctuate a lot when Repligen's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Repligen in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Repligen's short interest history, or implied volatility extrapolated from Repligen options trading.

Currently Active Assets on Macroaxis

Additionally, take a look at Repligen Piotroski F Score and Repligen Altman Z Score analysis. Note that the Repligen Cp information on this page should be used as a complementary analysis to other Repligen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for Repligen Stock analysis

When running Repligen Cp price analysis, check to measure Repligen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repligen is operating at the current time. Most of Repligen's value examination focuses on studying past and present price action to predict the probability of Repligen's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Repligen's price. Additionally, you may evaluate how the addition of Repligen to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Is Repligen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repligen. If investors know Repligen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repligen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.38
Market Capitalization
13.7 B
Quarterly Revenue Growth YOY
0.27
Return On Assets
0.0591
Return On Equity
0.0936
The market value of Repligen Cp is measured differently than its book value, which is the value of Repligen that is recorded on the company's balance sheet. Investors also form their own opinion of Repligen's value that differs from its market value or its book value, called intrinsic value, which is Repligen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repligen's market value can be influenced by many factors that don't directly affect Repligen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Repligen's value and its price as these two are different measures arrived at by different means. Investors typically determine Repligen value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repligen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.